Pharsight

Drugs that contain Epoprostenol Sodium

1. Veletri patents expiration

VELETRI's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8598227 ACTELION Epoprostenol formulation and method of making thereof
Feb, 2027

(2 years from now)

US8318802 ACTELION Epoprostenol formulation and method of making thereof
Mar, 2027

(2 years from now)

Market Authorisation Date: 28 June, 2012

Treatment: NA

Dosage: INJECTABLE;INJECTION

How can I launch a generic of VELETRI before it's drug patent expiration?
More Information on Dosage

VELETRI family patents

Family Patents